Real-world check: is BOSULIF safe and effective for leukemia patients?
NCT ID NCT06297161
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 18 times
Summary
This study looks at how safe and effective the drug BOSULIF is for people with chronic myeloid leukemia (CML) when used in normal medical practice. About 600 participants in Korea who are already taking or will start BOSULIF will be followed by their doctors. The goal is to track side effects and how well the drug controls the leukemia over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LEUKEMIA MYELOGENOUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pfizer New York
RECRUITINGNew York, New York, 10001, United States
Conditions
Explore the condition pages connected to this study.